Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis

Author: Greenwald M.   Peloso P.M.   Mandel D.   Soto O.   Frontera N.   Boice J.A.   Zhan X.J.   Curtis S.P.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.27, Iss.10, 2011-10, pp. : 2033-2042

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content